More specifically, a large number of thrombolysis studies in rodent stroke models demonstrate that t-PA is not neurotoxic and does not affect infarct size when administered early after stroke (including within 1 h as performed here and even when the dose of human t-PA is increased to 10 mg/kg) (4). This evidence concerns the gene PLAT and stroke disorder.